The DOI matches its Crossref record; 124 of the 130 references it cites were found in a registry or an index.
A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction
Abstract
Opioid dependence is a problem of national concern, especially with dramatically increased rates of abuse and dependence of prescription opioids. The current article provides an up-to-date review of the literature on opioid dependence treatment, with a focus on conclusions drawn by experts in the field (e.g., Cochrane reviews and meta-analyses) and methodologically rigorous studies (e.g., randomized controlled trials). We describe the major classes of drug treatments available, including opioid agonist (e.g., methadone, buprenorphine, LAAM), antagonist (e.g., naltrexone) and non-opioid pharmacotherapies (e.g., alpha2 adrenergic agonists). These treatments are discussed in the context of detoxification and long term treatment options such as abstinence-based and maintenance strategies. We review the state of the literature as to prevention of opioid overdose and discuss the widespread problem of comorbidity among opioid-dependent populations. We also focus prominently on evidence for inclusion of psychosocial approaches in treatment regimens, either as stand-alone or in conjunction with psychopharmacological options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a dearth of research investigating the efficacy of psychosocial treatments in reducing opioid use among people living with chronic pain.42,43”
Citations
Cites
2 retracted
Psychosocial treatment for opiate abuse and dependence
Mayet, S., Farrell, M., Ferri, M., Amato, L., & Davoli, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004330.pub2 · Cited by 106
RetractedPsychosocial treatment for opiate abuse and dependence
Mayet, S., Farrell, M., Ferri, M., Davoli, M., & Amato, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004330 · Cited by 12
RetractedMonitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Volume, I. I. (2017) · Institute for Social Research eBooks · doi:10.3998/2027.42/139710 · Cited by 1,369
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Results from the 2003 National Survey on Drug Use and Health: National Findings
(2004) · PsycEXTRA Dataset · doi:10.1037/e400442005-001 · Cited by 1,245
Flagged first, then by citations
6 of the 130 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Johnston, 2008, Monitoring the future national survey results on drug use, 1975–2007, Vol. 1.
- Maremmani, 2003, Dual diagnosis heroin addicts. The clinical and therapeutic aspects, Heroin Addiction and Related Clinical Problems, 5, 7
Cited by
Sorted by citations
Items 201–300 of 345
Venkateswaran, S., & Thirumalai, R. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176231222968 · Cited by 5
Newer approaches to opioid detoxification
Sarkar, S., & Mattoo, S. (2012) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.119652 · Cited by 5
Winstanley, E. L., Brigham, G. S., Babcock, D., & Winhusen, T. M. (2014) · Progress in community health partnerships · doi:10.1353/cpr.2014.0002 · Cited by 5
Walter, M., & Soyka, M. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00010-2 · Cited by 5
Smith, C. L., Keever, A., Bowden, T., Olson, K., Rodin, N. M., McDonell, M. G., Roll, J. M., Smoody, G., LeBrun, J., Miguel, A. C., et al. (2023) · JMIR Formative Research · doi:10.2196/40437 · Cited by 5
Allen, S. T., Schneider, K. E., Rouhani, S., White, R. H., Morris, M., Owczarzak, J., & Sherman, S. G. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2196435 · Cited by 5
Downey, C. A., & Chang, E. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0424-8_19 · Cited by 5
Buprenorphine: A New Alternative in the Treatment of Opioid Addiction
Tellioğlu, T. (2010) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2010.11790670 · Cited by 5
Mutter, R. L., Feder, K. A., & Ali, M. M. (2019) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000185 · Cited by 5
Chang, Y., & Raynor, T. (2021) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000381 · Cited by 5
Public policy, attitudes and willingness to pay for treatment of substance dependence in Iran
Moghaddam, S. A., Mazyaki, A., & Razaghi, E. M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.08.005 · Cited by 5
Dannatt, L., Cloete, K. J., Kidd, M., & Weich, L. (2014) · South African Journal of Psychiatry · doi:10.7196/sajp.540 · Cited by 5
Stevenson, E., & Cole, J. (2015) · American Journal on Addictions · doi:10.1111/ajad.12151 · Cited by 5
Adolescents at Risk: Pain Pills to Heroin: Part II
Fogger, S. A., & McGuinness, T. M. (2015) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20150106-01 · Cited by 5
The Theory of Hedonic Motivation
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.017 · Cited by 3
Take-home naloxone in opioid dependency
Fleißner, S., Stöver, H., Schäffer, D., Essen, H. W.-V., Deimel, D., & Wodarz, N. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0030 · Cited by 4
Adult Neural Stem Cells as Promising Targets in Psychiatric Disorders
Rodrigues, R. S., Paulo, S. L., Moreira, J. B., Tanqueiro, S. R., Sebastião, A. M., Diógenes, M. J., & Xapelli, S. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0100 · Cited by 4
Zeledon, I., Telles, V. M., Dickerson, D. L., Johnson, C. L., Schweigman, K., West, A. E., & Soto, C. (2022) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2022.83.613 · Cited by 5
Correlates of death during outpatient treatment for opioid use disorder: A national study
Goldman, J. A., Samuels, E. A., Rich, J. D., & Marshall, B. D. L. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.003 · Cited by 4
Okolie, C., Evans, B. A., John, A. M., Moore, C., Russell, D., & Snooks, H. A. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008981 · Cited by 4
Reducing Problematic Benzodiazepine Use Among Individuals Enrolled in Methadone Treatment Programs
Schuster, J. M., Loveland, D., Parthasarathy, M., Maiolo, N., Cilia, A., & Castelnovo, K. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000216 · Cited by 4
Haghbin, M. A., Navidi, Z., Leguizamón, C. R. R., & Shabani, M. (2018) · Europe PMC (PubMed Central) · doi:10.22122/ahj.v10i2.538 · Cited by 3
Dadvand, S. S., & Arazi, H. (2018) · Baltic Journal of Sport and Health Sciences · doi:10.33607/bjshs.v4i111.673 · Cited by 3
Hajiha, Z., & Ehsan, H. B. (2021) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2021.1935380 · Cited by 3
Greydanus, D. E., Nazeer, A., & Patel, D. R. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.101853 · Cited by 4
Kenny, K., & O’Carroll, A. (2011) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-011-0745-x · Cited by 3
Introduction to Substance Use Disorders for the Eating Disorder Specialist
Dennis, A. B., & Pryor, T. L. (2014) · Springer eBooks · doi:10.1007/978-3-642-45378-6_12 · Cited by 3
Opioids: Literature Findings and Recommendations
Jones, H., & Arms, T. E. (2018) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20180703-01 · Cited by 3
Moghaddam, S. A., Roshanpajouh, M., Mazyaki, A., Amiri, M., & Razaghi, E. M. (2020) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.98718 · Cited by 3
Tithy, S. A., Hossain, M. M., Shill, D. K., Hossain, M. S., Islam, A., Molla, M. I., & Jahan, S. (2024) · Dhaka University Journal of Pharmaceutical Sciences · doi:10.3329/dujps.v23i1.74097 · Cited by 2
Quintana, S., Aarons, G. A., Coser, A. D., Kominsky, T. K., Martin, L., Tsurnos, S., & Novins, D. K. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209635 · Cited by 2
Fischer, B., Burnett, C., & Rehm, J. T. (2014) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2014.936827 · Cited by 2
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation
Caprioli, G., Mammoli, V., Ricciutelli, M., Sagratini, G., Ubaldi, M., Domi, E., Mennuni, L., Sabatini, C., Galimberti, C., Ferrari, F., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.021 · Cited by 2
Go, S., Kim, J. H., Lee, G., & Kang, J. H. (2018) · The Korean Journal of Hospice and Palliative Care · doi:10.14475/kjhpc.2018.21.4.152 · Cited by 2
Buchanan, A. L., Sun, T., Wu, J. H., Aroke, H. A., Bratberg, J. P., Rich, J. D., Kogut, S. J., & Hogan, J. W. (2022) · Statistics in Medicine · doi:10.1002/sim.9427 · Cited by 2
Clingan, S. E., Woodruff, S. I., Gaines, T. L., & Davidson, P. J. (2022) · Journal of Addictive Diseases · doi:10.1080/10550887.2022.2108287 · Cited by 2
Huxley, A. (2017) · Addiction · doi:10.1002/9781118489710.ch10 · Cited by 2
Rowe, C. L., Williams, A. R., & Bisaga, A. M. (2024) · Substance Use & Addiction Journal · doi:10.1177/29767342241283174 · Cited by 1
Bacopa monnieri inhibits locomotor hyperactivity induced by morphine without altering noradrenaline
Rauf, K., Subhan, F., Abbas, G., Ali, G., Mobasher, S., Ali, A., Arshad, U., Junaid, M., & Sharif, H. (2013) · Cited by 1
Baseline characteristics of patients predicting suitability for rapid naltrexone induction
Mogali, S., Khan, N. A., Drill, E. S., Pavlicová, M., Sullivan, M. A., Nunes, E. V., & Bisaga, A. M. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12180.x · Cited by 1
Opioid Dependence and the Adenylyl Cyclase/cAMP Signaling
Yang, H., Nagpure, B. V., & Bian, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00044-5 · Cited by 1
El estado actual de las vacunas contra las drogas
Matus-Ortega, M., Nieves, J. C. C., Barbosa-Méndez, S., & Salazar‐Juárez, A. (2017) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2017.2.05 · Cited by 1
On the Preventative Effect of Sanctions for Drug Crime: The United States, Germany, and Portugal
Kury, H., Kuhlmann, A., & Quintas, J. (2019) · Archiwum Kryminologii. · doi:10.7420/ak2019f · Cited by 1
Jamil, N. K. M., Nurul, A. A., Ahmad, I., Ismail, S., & Bakar, R. A. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i3.52799 · Cited by 1
The Evolutionary Function of Psychological Hedonism
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.020 · Cited by 1
Sharp, A., Carlson, M., Vroom, E. B., Rigg, K. K., Hills, H. A., Harding, C., Moore, K. A., & Schuman‐Olivier, Z. (2023) · Implementation Research and Practice · doi:10.1177/26334895231205890 · Cited by 1
Kvamme, T. L., Thylstrup, B., & Hesse, M. (2024) · Journal of Psychosocial Rehabilitation and Mental Health · doi:10.1007/s40737-024-00398-z · Cited by 1
Health-Promoting Lifestyle Factors Among Opioid-Dependent Patients: A Scoping Review
Negi, P. S., Mathur, R., & Sarkar, S. (2023) · Journal of SAARC Psychiatric Federation · doi:10.4103/jspf.jspf_1_24 · Cited by 1
Khamooshi, F., Doraji-Bonjar, S., Ghaznavi, H., Mohammadi, M. H., Modarresi‐Alam, A. R., Navidian, A., Khajeh, A., & Momeni, M. K. (2025) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2502289 · Cited by 2
Taherifard, M., & Abolghasemi, A. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Joint Trajectories of Heroin Use and Treatment Utilisation: Who Will Benefit in the Long Term?
Dong, H., & Kerr, T. H. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.08.001 · Cited by 1
Disease, wellness, and addiction: A global perspective
Barnett, A., Hall, W., & Carter, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815063-4.00013-7 · Cited by 1
Examining a migration-based phenomenon of heroin use in an urban drug scene in Sao Paulo, Brazil
Ribeiro, M., Frajzinger, R., Perrenoud, L. O., & Fischer, B. (2021) · International Journal of Migration Health and Social Care · doi:10.1108/ijmhsc-06-2020-0065 · Cited by 1
Darwinian Hedonism and Hedonic Dread of Physical Activity
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.025 · Cited by 1
Literature review on withdrawal management
LaMarre, A. (2015) · The Atrium (University of Guelph) · Cited by 1
McLean, C. (2015) · Summit (Simon Fraser University)
Assessment of nutritional status in pregnant women on opioid maintenance therapy
Shrestha, S. (2015) · UNM’s Digital Repository (University of New Mexico)
EXAMINING CHRONIC NON-CANCER PAIN AMONG A SAMPLE OF INDIVIDUALS IN OPIOID TREATMENT PROGRAMS
Stevenson, E. (2012) · UKnowledge (University of Kentucky)
Ashrafioun, L. (2014) · ScholarWorks@BGSU (Bowling Green State University)
Methadone maintenance therapy in the United States: a case example of dual diagnosis
Campopiano, M. (2010) · Advances in Dual Diagnosis · doi:10.5042/add.2010.0746
Role of ALDH5A1 in Methadone Treatment
Torrens, M., & Fonseca, F. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.13
Scotland, T. I. (2013)
The effect of 12 weeks of exercise on prevention of addiction relapse in women treated
Maral, H., Hojjat, S., & Hajirasouli, M. (2013)
Carlos, I., Henao, J., Leonardo, B., Porras-Hurtado, L., Martha, G., Raquel, C., & Angel, C. (2013)
An Architecturally Relevant Model for Creating Orientation Maps of Primary Visual Cortex
(7933811), J. E. A. (2013) · Figshare
Identification and Modulation of Esterases Involved in the Metabolism of Heroin
Hauan, K. M. (2014) · NORA - Norwegian Open Research Archives
Psychiatry and Oncologic Emergencies
González, R. O., Thekdi, S. M., & Rashid, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26387-8_32
Zubatsky, M., Mendenhall, T. J., Fowler, J., & Harris, S. M. (2017) · American Journal of Family Therapy · doi:10.1080/01926187.2017.1322927
Methadone Usage, Misuse, and Addiction Processes
Li, Z., & Xi, Z. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00038-x
Harm Reduction for Injection Drug Users
Kuo, I. C., & Phillips, G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_110-1
Stevenson, E., & Cole, J. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12151.x
Synthesis of Analogues Based on the Opioid Alkaloid Mitragynine
Arribas, M. A. (2010)
Public Attitudes Towards Heroin Addictions: Spatial Consequences for Treatment Options and Access
Johnson, M. L., Hartnett, C., & Ostermeier, A. (2017) · Minds at UW (University of Wisconsin)
Dale, L. M., & Nosyk, B. (2020) · Addiction · doi:10.1111/add.15045
Darwinian Hedonism and Unhealthy Behavior
Williams, D. M. (2019)
What Are the Causes of Unhealthy Behavior?
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.007
Hedonic Motivation versus Reflective Motivation
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.015
Pleasure, Displeasure, and Affective Valence
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.010
Psychological Hedonism and Its Problems
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.008
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.027
Reward, Incentive Salience, and Hedonic Motivation
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.013
Reformulating Psychological Hedonism
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.009
Understanding the Causes of Behavior
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.004
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.012
What can Jane Goodall teach us about addiction?
Frisher, M. (2022) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2022.2033164
The Phylogenetic Development of Psychological Hedonism
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.021
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.018
From Hedonic Motivation to Unhealthy Behavior
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.016
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.022
Darwinian Hedonism and Political Will
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.029
Darwinian Hedonism and Hedonic Desire for Calorie-Dense Foods
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.024
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.001
Conclusions and Future Directions
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.030
Fulton, B. S. (2014) · Wiley eBooks · doi:10.1002/9781118943670.refs
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.002
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.033
The Epidemic of Unhealthy Behavior
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.003
Darwinian Hedonism and Hedonic Desire for Smoking, Drinking, and Drug Use
Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047.026
Metadata
- Authors
- Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Veilleux, Jennifer C.
- Venue
- Clinical Psychology Review
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 30
- Issue
- 2
- Pages
- 155-166
- ISSN
- 0272-7358 (ISSN-L)
- OpenAlex
- W2038833041
- Cited by
- 336
- References
- 130
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 11 · 2023: 13 · 2022: 21 · 2021: 12 · 2020: 24 · 2019: 62 · 2018: 24 · 2017: 22 · 2016: 18 · 2015: 24 · 2014: 29 · 2013: 22 · 2012: 20
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Psychology Review (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid use disorder, opioid dependence treatment, pharmacological interventions, psychosocial interventions, methadone, buprenorphine, LAAM, naltrexone, alpha-2 adrenergic agonists, opioid agonists, opioid antagonists, opioid detoxification, abstinence-based treatment, maintenance therapy, opioid overdose prevention, comorbidities, prescription opioid abuse
- MeSH terms
- Biofeedback, Psychology, Humans, Narcotic Antagonists, Opioid-Related Disorders, Narcotics, Self-Help Groups, Cognitive Behavioral Therapy, Prevalence, Adrenergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review